6.75
전일 마감가:
$6.49
열려 있는:
$6.605
하루 거래량:
85,666
Relative Volume:
1.19
시가총액:
$146.98M
수익:
$10.22M
순이익/손실:
$-20.67M
주가수익비율:
-5.7354
EPS:
-1.1769
순현금흐름:
$-20.72M
1주 성능:
+1.73%
1개월 성능:
+17.39%
6개월 성능:
-6.64%
1년 성능:
+46.42%
Alpha Cognition Inc Stock (ACOG) Company Profile
명칭
Alpha Cognition Inc
전화
(858) 344-4375
주소
1452 HUGHES RD., STE. 200, GRAPEVINE
Compare ACOG vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ACOG
Alpha Cognition Inc
|
6.75 | 141.31M | 10.22M | -20.67M | -20.72M | -1.1769 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-18 | 개시 | H.C. Wainwright | Buy |
Alpha Cognition Inc 주식(ACOG)의 최신 뉴스
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
Alpha Cognition Inc. (ACOG) soars 8.6%: Is further upside left in the stock? - MSN
Alpha Cognition Inc enters settlement agreement with Galantos Pharma on April 10, 2026SEC filing - marketscreener.com
Alpha Cognition IncEnters Settlement Agreement With Galantos Pharma On April 10, 2026SEC Filing - TradingView — Track All Markets
[8-K] Alpha Cognition Inc. Reports Material Event - Stock Titan
Alpha Cognition Earnings Call: Early Traction, Rising Costs - TipRanks
Is Alpha Cognition Inc a strong candidate for buy and hold2026 Macro Moves & Safe Entry Trade Reports - baoquankhu1.vn
Aug Reactions: Whats the MACD signal for Alpha Cognition Inc2026 Closing Moves & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aug Swings: Will Alpha Cognition Inc announce a stock splitMarket Volume Summary & Stock Timing and Entry Methods - baoquankhu1.vn
Sell Signal: What are the analyst revisions for BBAIWSIs Alpha Cognition Inc stock a good investment in YEARGap Up & Daily Entry Point Trade Alerts - baoquankhu1.vn
Portfolio Recap: What are the analyst revisions for BBAIWSIs Alpha Cognition Inc stock a good investment in YEAR2026 Key Highlights & Verified Short-Term Trading Plans - baoquankhu1.vn
Alpha Cognition Inc (OTC:ACOGF) Stock Quote - The Chronicle-Journal
Movement Recap: Can Alpha Cognition Inc stock double in the next yearMarket Trend Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
Alpha Cognition (NASDAQ:ACOG) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Alpha Cognition Inc. (ACOG) Jumps 8.6%: Does the Stock Have More Room to Grow? - Bitget
Alpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury - BioSpace
Opaleye Management Inc. Increases Stake in Alpha Cognition Inc. - GuruFocus
Alpha Cognition receives U.S. patent for traumatic brain injury drug By Investing.com - Investing.com Australia
Alpha Cognition receives issued U.S. patent for Alpha-1062 for treatment of traumatic brain injury - marketscreener.com
Alpha Cognition Receives Issued U.S. Patent For Alpha-1062 For Treatment Of Traumatic Brain Injury - TradingView — Track All Markets
Alpha Cognition receives U.S. patent for traumatic brain injury drug - Investing.com
Alpha Cognition Gets US Patent for ALPHA-1062 in Traumatic Brain Injury - marketscreener.com
Alpha Cognition Reports Strong ZUNVEYL Adoption in Long-Term Care Facilities - citybuzz -
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425 - Nasdaq
Alpha Cognition (ACOG) Q4 2025 Earnings Transcript - The Globe and Mail
EV Market: Will Alpha Cognition Inc benefit from geopolitical trendsQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn
Alpha Cognition (NASDAQ: ACOG) outlines ZUNVEYL launch, $44M license and Alzheimer’s pipeline - Stock Titan
Opaleye fund adds Alpha Cognition (ACOG) stake with new share purchases - Stock Titan
Aug PreEarnings: Does Alpha Cognition Inc have declining or rising EPS2026 Geopolitical Influence & Technical Pattern Recognition Alerts - baoquankhu1.vn
Can Alpha Cognition Inc outperform under higher oil prices2026 AllTime Highs & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Alpha Cognition Reports Q4 Earnings, Highlights Continued ZUNVEYL Growth - National Today
Alpha Cognition (NASDAQ:ACOG) Posts Earnings Results, Misses Estimates By $0.03 EPS - marketbeat.com
Alpha Cognition Inc. Announces 2026 Annual General Meeting Date and Details for Security Holders - Minichart
Alpha Cognition Q4 Earnings Call Highlights - Defense World
Alpha Cognition schedules annual shareholder meeting for June 16 - uk.investing.com
Alpha Cognition schedules annual shareholder meeting for June 16 By Investing.com - Investing.com India
Alpha Cognition (NASDAQ: ACOG) sets June 16, 2026 annual shareholder meeting - Stock Titan
Alpha Cognition Inc. Common Stock Q4 2025 Earnings Call Summary - Yahoo Finance
Alpha Cognition reports Q4 revenue of $2.5M for Alzheimer’s drug - Investing.com Australia
Major Investor Quietly Boosts Stake in Alpha Cognition Inc. - TipRanks
Alpha Cognition Q4 2025 Earnings Call Transcript - MarketBeat
Alpha Cognition Inc. (ACOG) reports Q4 loss, lags revenue estimates - MSN
Alpha Cognition Inc (ACOG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):